Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid cancer incidence and mortality in the United States, 1974-2013. JAMA. 2017;317(13):1338–48. https://doi.org/10.1001/jama.2017.2719.

Article  PubMed  PubMed Central  Google Scholar 

Lin B, Ma H, Ma M, et al. The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis. Am J Transl Res. 2019;11(9):5888–96.

PubMed  PubMed Central  Google Scholar 

Kebebew E, Greenspan FS, Clark OH, Woeber KA, McMillan A. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors. Cancer. 2005;103(7):1330–5. https://doi.org/10.1002/cncr.20936.

Article  PubMed  Google Scholar 

Duan H, Li Y, Hu P, et al. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing. Histopathology. 2019;75(6):890–9. https://doi.org/10.1111/his.13942.

Article  PubMed  Google Scholar 

Kunstman JW, Juhlin CC, Goh G, et al. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing. Hum Mol Genet. 2015;24(8):2318–29. https://doi.org/10.1093/hmg/ddu749.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skwiersky S, Hevroni G, Singh G, et al. Concurrent anaplastic and papillary thyroid carcinomas: a case report. Am J Med Case Rep. 2020;8(7):202–5.

Article  Google Scholar 

Shahi S, Bhandari TR, Pantha T, Gautam D. A rare coexistence of papillary carcinoma and anaplastic carcinoma of thyroid in multinodular goitre: case report and literature review. Ann Med Surg. 2020;56:161–4. https://doi.org/10.1016/j.amsu.2020.06.024.

Article  Google Scholar 

Khairy G. Anaplastic transformation of differentiated thyroid carcinoma. Int J Health Sci. 2009;3(1):93–6.

Google Scholar 

Maniakas A, Dadu R, Busaidy NL, et al. Evaluation of overall survival in patients with anaplastic thyroid carcinoma, 2000-2019. JAMA Oncol. 2020;6(9):1397–404. https://doi.org/10.1001/jamaoncol.2020.3362.

Article  PubMed  Google Scholar 

Khan SA, Ci B, Xie Y, et al. Unique mutation patterns in anaplastic thyroid cancer identified by comprehensive genomic profiling. Head Neck. 2019;41(6):1928–34. https://doi.org/10.1002/hed.25634.

Article  PubMed  PubMed Central  Google Scholar 

Survival Rates for Thyroid Cancer. https://www.cancer.org/cancer/thyroid-cancer/detection-diagnosis-staging/survival-rates.html. Accessed 30 May 2024.

Patel S, Pappoppula L, Guddati AK, Annamaraju P. Analysis of Race and Gender Disparities in Incidence-Based Mortality in Patients Diagnosed with Thyroid Cancer from 2000 to 2016. Int J Gen Med. 2020;13:1589–94. https://doi.org/10.2147/IJGM.S280986.

Article  PubMed  PubMed Central  Google Scholar 

• Sherman EJ, Harris J, Bible KC, et al. Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial. Lancet Oncol. 2023;24(2):175–86. https://doi.org/10.1016/S1470-2045(22)00763-X. This reference is of importance as this is the largest clinical trial for anaplastic thyroid cancer which explored the addition of pazopanib to the combination of paclitaxel and radiotherapy. Although it showed pazopanib to be a safe addition to the combination, there is no statistically significant improvement of survival in the intervention group versus placebo.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Subbiah V, Wolf J, Konda B, et al. Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial. Lancet Oncol. 2022;23(10):1261–73. https://doi.org/10.1016/S1470-2045(22)00541-1.

Article  CAS  PubMed  Google Scholar 

Landa I, Ibrahimpasic T, Boucai L, et al. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Invest. 2016;126(3):1052–66. https://doi.org/10.1172/JCI85271.

Article  PubMed  PubMed Central  Google Scholar 

Volante M, Lam AK, Papotti M, Tallini G. Molecular pathology of poorly differentiated and anaplastic thyroid cancer: what do pathologists need to know? Endocr Pathol. 2021;32(1):63–76. https://doi.org/10.1007/s12022-021-09665-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kong N, Xu Q, Zhang Z, Cui A, Tan S, Bai N. Age influences the prognosis of anaplastic thyroid cancer patients. Front Endocrinol. 2021;12. https://www.frontiersin.org/article/10.3389/fendo.2021.704596.

Jin S, Borkhuu O, Bao W, Yang YT. Signaling pathways in thyroid cancer and their therapeutic implications. J Clin Med Res. 2016;8(4):284–96. https://doi.org/10.14740/jocmr2480w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zivaljevic V, Slijepcevic N, Paunovic I, et al. Risk factors for anaplastic thyroid cancer. Int J Endocrinol. 2014;2014:815070. https://doi.org/10.1155/2014/815070.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McIver B, Hay ID, Giuffrida DF, et al. Anaplastic thyroid carcinoma: a 50-year experience at a single institution. Surgery. 2001;130(6):1028–34. https://doi.org/10.1067/msy.2001.118266.

Article  CAS  PubMed  Google Scholar 

Spires JR, Schwartz MR, Miller RH. Anaplastic thyroid carcinoma. Association with differentiated thyroid cancer. Arch Otolaryngol Head Neck Surg. 1988;114(1):40–4. https://doi.org/10.1001/archotol.1988.01860130044012.

Article  CAS  PubMed  Google Scholar 

Wallin G, Bäckdahl M, Tallroth-Ekman E, Lundell G, Auer G, Löwhagen T. Co-existent anaplastic and well differentiated thyroid carcinomas: a nuclear DNA study. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 1989;15(1):43–8.

CAS  Google Scholar 

Molinaro E, Romei C, Biagini A, et al. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies. Nat Rev Endocrinol. 2017;13(11):644–60. https://doi.org/10.1038/nrendo.2017.76.

Article  CAS  PubMed  Google Scholar 

Ibrahimpasic T, Ghossein R, Shah JP, Ganly I. Poorly differentiated carcinoma of the thyroid gland: current status and future prospects. Thyroid. 2019;29(3):311–21. https://doi.org/10.1089/thy.2018.0509.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matrone A, De Napoli L, Torregrossa L, et al. Core needle biopsy can early and precisely identify large thyroid masses. Front Oncol. 2022;12:854755. https://doi.org/10.3389/fonc.2022.854755.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qin Y, Wang JR, Wang Y, et al. Clinical utility of circulating cell-free dna mutations in anaplastic thyroid carcinoma. Thyroid. 2021;31(8):1235–43. https://doi.org/10.1089/thy.2020.0296.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marotta V, Cennamo M, La Civita E, Vitale M, Terracciano D. Cell-Free DNA analysis within the challenges of thyroid cancer management. Cancers. 2022;14(21):5370. https://doi.org/10.3390/cancers14215370.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landa I, Pozdeyev N, Korch C, et al. Comprehensive genetic characterization of human thyroid cancer cell lines: a validated panel for preclinical studies. Clin Cancer Res. 2019;25(10):3141–51. https://doi.org/10.1158/1078-0432.CCR-18-2953.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franco AT, Malaguarnera R, Refetoff S, et al. Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proc Natl Acad Sci. 2011;108(4):1615–20. https://doi.org/10.1073/pnas.1015557108.

Article  PubMed  PubMed Central  Google Scholar 

Kasaian K, Wiseman SM, Walker BA, et al. The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy. BMC Cancer. 2015;15(1):984. https://doi.org/10.1186/s12885-015-1955-9.

Article  CAS